Hear from our team on recent breakthroughs, scientific and clinical advancements, company culture, and our ongoing work to develop new medicines at Kymera.
When Aimee Mishkin joined Kymera as our first regulatory hire, she had the rare opportunity to build a function from scratch. Six years later, she reflects on helping chart new development paths for our first-in-class oral degrader medicines, the team she’s built, and why new perspectives will help amplify innovation as the company grows.

Stay ahead with the latest news from Kymera. Our Press Releases provide insights into our recent achievements and future endeavors.
Related Stories